HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Lucid Capital Markets initiates Microbot Medical stock with buy rating

Created at 3 Jun · 12:20 PM1 source
IN SHORT

Lucid Capital Markets has initiated coverage of Microbot Medical stock with a buy rating, indicating a positive outlook on the company's future stock performance.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Who's Involved

Lucid Capital Markets
Initiated coverage of Microbot Medical stock with a buy rating
Microbot Medical
Stock subject to new buy rating from Lucid Capital Markets

↳ Why This Matters

An analyst initiation with a buy rating can influence investor sentiment and potentially lead to increased interest and trading activity in Microbot Medical's stock.

Key facts

  • Lucid Capital Markets initiated coverage of Microbot Medical stock.
  • The rating assigned was a 'buy'.

Lucid Capital Markets has initiated coverage of Microbot Medical stock, assigning it a 'buy' rating. This move signals a positive perspective from Lucid Capital Markets regarding the potential performance of Microbot Medical's stock.

Frequently asked questions

Lucid Capital Markets initiated coverage of Microbot Medical stock.

Lucid Capital Markets assigned a 'buy' rating.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

3 Jun · 12:01 PM
Lucid Capital Markets initiated Microbot Medical stock with a buy rating, indicating a positive outlook.
Investing.com via PiQSuite

Sources

T1
Lucid Capital Markets initiates Microbot Medical stock with buy ratingm.piqsuite.com

Related Stories

Michael Burry Buys Flutter, DraftKings Shares on Prediction Market Threat
8 Jul · 9:51 PM
JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM
Zhipu AI Shares Rise After Lockup Expiry Amid Investor Support
8 Jul · 8:25 PM
Goldman Sachs forecasts 50% jump for CATL shares amid energy storage growth
9 Jul · 2:40 AM
AI and SpaceX Wealth Fuels New Luxury Spending Habits
8 Jul · 10:06 AM